Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Creo Medical ( (GB:CREO) ) has provided an announcement.
Creo Medical Group PLC has announced that its Non-Executive Chairman, Kevin T. Crofton, has acquired 1,179,000 ordinary shares of the company, increasing his total shareholding to 4,745,666, representing 1.15% of voting rights. This transaction reflects a strategic move within the company, potentially signaling confidence in its ongoing operations and future prospects, which could impact stakeholders and influence market perceptions.
More about Creo Medical
Creo Medical is a medical device company specializing in minimally invasive electrosurgical devices aimed at enhancing endoscopy procedures. The company focuses on improving patient outcomes through its advanced CROMA technology powered by Kamaptive, offering a suite of devices that enable precise and controlled surgical solutions.
YTD Price Performance: -63.32%
Average Trading Volume: 1,011,361
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £69.55M
Learn more about CREO stock on TipRanks’ Stock Analysis page.
